Asymmetry Capital Management as of March 31, 2016
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 16 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| XenoPort | 19.1 | $7.3M | 1.6M | 4.51 | |
| Eli Lilly & Co. (LLY) | 12.3 | $4.7M | 65k | 72.00 | |
| Quest Diagnostics Incorporated (DGX) | 11.8 | $4.5M | 64k | 71.45 | |
| Amicus Therapeutics (FOLD) | 7.3 | $2.8M | 334k | 8.45 | |
| Nevro (NVRO) | 7.2 | $2.8M | 49k | 56.26 | |
| Neurocrine Biosciences (NBIX) | 6.5 | $2.5M | 63k | 39.55 | |
| UnitedHealth (UNH) | 6.0 | $2.3M | 18k | 128.88 | |
| Teva Pharmaceutical Industries (TEVA) | 5.8 | $2.2M | 41k | 53.50 | |
| Impax Laboratories | 5.2 | $2.0M | 62k | 32.02 | |
| Aerie Pharmaceuticals | 4.5 | $1.7M | 141k | 12.16 | |
| BIO-RAD LABORATORIES Inc Cl A Com Stk | 4.3 | $1.6M | 12k | 136.68 | |
| Edwards Lifesciences (EW) | 3.6 | $1.4M | 16k | 88.21 | |
| Centene Corporation (CNC) | 1.9 | $730k | 12k | 61.60 | |
| Quidel Corporation | 1.9 | $717k | 42k | 17.26 | |
| OraSure Technologies (OSUR) | 1.3 | $500k | 69k | 7.23 | |
| Anacor Pharmaceuticals In | 1.2 | $473k | 8.9k | 53.45 |
